本文章的学术内容和语言评估
本文章的学术规范
本文章的引用
本文章的通讯作者
本文章的研究领域
本文章的类型
本文章的开放获取政策
本文章的Google引用次数
本文章的点击和下载次数
- 本文章浏览次数 (7590)
All Articles published online
|
Publishing Process of This Article
|
Dec 28, 2021 (publication date) through Oct 19, 2024
本文章的被引频次
本文章的期刊信息
出版物名称
World Journal of Gastroenterology
ISSN
1007-9327
本文章的出版商
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Cheng WX, Ren Y, Lu MM, Xu LL, Gao JG, Chen D, Kalyani FS, Lv ZY, Chen CX, Ji F, Lin HN, Jin X. Palmitoylation in Crohn’s disease: Current status and future directions. World J Gastroenterol 2021; 27(48): 8201-8215 [PMID: 35068865 DOI: 10.3748/wjg.v27.i48.8201] |
|---|---|
| URL: | https://www.wjgnet.com/1009-3079/full/v27/i48/8201.htm |
| 编号 | Citing Articles |
| 1 |
Ying Zhang, Sisi Fan, Lu He, Lanfang Li. The ZDHHC13/ZDHHC17 subfamily: From biological functions to therapeutic targets of diseases. Pharmacological Research 2024; 209: 107418 doi: 10.1016/j.phrs.2024.107418
|
| 2 |
Xiaoqian Li, Tao Yu, Xiaolu Li, Xiangqin He, Bei Zhang, Yanyan Yang. Role of novel protein acylation modifications in immunity and its related diseases. Immunology 2024; 173(1): 53 doi: 10.1111/imm.13822
|
| 3 |
Xinyi Mao, Jun Shen. Potential roles of enteric glial cells in Crohn's disease: A critical review. Cell Proliferation 2024; 57(1) doi: 10.1111/cpr.13536
|
| 4 |
Ling Xu, Bin Zhao, Haihe Cheng, Gang Li, Yan Sun. Bergapten enhances mitophagy to regulate intestinal barrier and Th17/Treg balance in mice with Crohn’s disease-like colitis via PPARγ/NF-κB signaling pathway. Naunyn-Schmiedeberg's Archives of Pharmacology 2024; 397(10): 7589 doi: 10.1007/s00210-024-03113-8
|
| 5 |
Zihan Chen, Ping Jiang, Dan Su, Yu Zhao, Mingming Zhang. Therapeutic inhibition of the JAK-STAT pathway in the treatment of inflammatory bowel disease. Cytokine & Growth Factor Reviews 2024; 79: 1 doi: 10.1016/j.cytogfr.2024.07.008
|
| 6 |
Sarah L. Speck, Xiaochao Wei, Clay F. Semenkovich. Depalmitoylation and cell physiology: APT1 as a mediator of metabolic signals. American Journal of Physiology-Cell Physiology 2024; 326(4): C1034 doi: 10.1152/ajpcell.00542.2023
|
| 7 |
Meiqin Shen, Yingqi Shi, Zhenming Ge, Junbo Qian. Effects of Mesalamine Combined with Live Combined Bifidobacterium, Lactobacillus and Enterococcus Capsules on Intestinal Mucosa Barrier Function and Intestinal Microbiota in Mildly Active Crohn’s Disease Patients. Journal of Investigative Surgery 2024; 37(1) doi: 10.1080/08941939.2023.2297565
|
| 8 |
Jing Cai, Jun Cui, Liqiu Wang. S‐palmitoylation regulates innate immune signaling pathways: molecular mechanisms and targeted therapies. European Journal of Immunology 2023; 53(10) doi: 10.1002/eji.202350476
|
| 9 |
Yijing Peng, Yizhe Ma, Zichen Luo, Yifan Jiang, Zhimin Xu, Renqiang Yu. Lactobacillus reuteri in digestive system diseases: focus on clinical trials and mechanisms. Frontiers in Cellular and Infection Microbiology 2023; 13 doi: 10.3389/fcimb.2023.1254198
|
| 10 |
Sonali Bhardwaj, Mitchell Bulluss, Ana D'Aubeterre, Afshin Derakhshani, Regan Penner, MaryAnn Mahajan, Vinit B. Mahajan, Antoine Dufour. Integrating the analysis of human biopsies using post‐translational modifications proteomics. Protein Science 2024; 33(4) doi: 10.1002/pro.4979
|